| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.098 | 0.1 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.1 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.05 | 0.1 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |